OraSure Technologies, Inc. (NASDAQ:OSUR) Q3 2024 Earnings Conference Call November 6, 2024 5:00 PM ET

Company Participants

Jason Plagman - VP of Investor Relations
Carrie Eglinton Manner - President & Chief Executive Officer
Kenneth McGrath - Chief Financial Officer

Conference Call Participants

Vijay Kumar - Evercore ISI
Casey Woodring - JPMorgan

Operator

Good day, and thank you for standing by. Welcome to the OraSure Technologies Inc. 2024 Third Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your first speaker today, Jason Plagman, Vice President of Investor Relations. Please go ahead.

Jason Plagman

Good afternoon, and welcome to OraSure Technologies' third quarter 2024 earnings call. Participating in the call today for OTI are Carrie Eglinton Manner, our President and Chief Executive Officer; and Ken McGrath, our Chief Financial Officer. As a reminder, today's webcast is being recorded, and the recording can be found on our Investor Relations website.

Before we begin, you should know that this call may contain certain forward-looking statements, including statements with respect to revenues, expenses, profitability, earnings or loss per share and other financial performance, product development, performance, shipments, end markets, business plans, regulatory filings and approvals, expectations and strategies. Actual results could be significantly different.

Factors that could affect results are discussed more fully in OTI's SEC filings, its annual report on Form 10-K for the year ended December 31, 2023, its quarterly reports on Form 10-Q and its other SEC filings. Although forward-looking statements help to provide more complete information about future prospects, listeners should keep in mind that forward-looking statements are based solely on information available to management as of today. OTI undertakes no obligation to update any forward-looking statements to reflect events or circumstances after this call.

With that, I'm pleased to turn the call over to Carrie.

Carrie Eglinton Manner

Thanks, Jason, and thank you to everyone for joining us today. We are pleased to provide an update on the progress OraSure's making on the three pillars of our strategic transformation, one, strengthening our foundation, two, elevating our core growth, and three, accelerating profitable growth.

A few notable developments during the third quarter include we delivered Q3 revenue that was on the top half of our guidance ranges for core revenue and total revenue. We received initial international orders for our OraQuick HCV Self-Test following receipt of WHO prequalification status in July. The OraQuick HCV Self-Test is the first hepatitis C Self-Test to earn this designation and we look forward to expanding access to this important test.